Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Novo Seeds portfolio company NorthSea Therapeutics raises US40m in Series B financing

Novo Seeds' portfolio company, NorthSea Therapeutics a Dutch biotech company developing novel and innovative strategies for the treatment of NASH (Non-alcoholic Steatohepatitis) and other metabolic, inflammatory and fibrotic diseases, has successfully closed a USD40 million (EUR36 million) Series B financing round. The proceeds of this fundraising will be used by NorthSea to drive the development of its pipeline of SEFA (Structural Engineered Fatty Acids) programs.